Generated by AI
Tenax Therapeutics, Inc. is a development-stage pharmaceutical company focused on cardiopulmonary therapies. The company develops treatments for serious cardiovascular and pulmonary conditions, with a primary emphasis on pulmonary hypertension associated with heart failure with preserved ejection fraction. Its pipeline includes levosimendan-based programs, as well as other drug candidates aimed at improving outcomes in heart and lung disease. Tenax Therapeutics concentrates on advancing clinical-stage therapies for patients with high unmet medical needs, making it a specialized player in the pharmaceutical market. Headquartered in Chapel Hill, North Carolina, Tenax Therapeutics operates as a research-driven company centered on novel treatments for complex cardiopulmonary disorders.
Website101 Glen Lennox Drive
Chapel Hill, NC, 27517
United States
The latest articles about TENX.
Summary of Oct 29's posts. Generated by AI.
Summary of Sep 9's posts. Generated by AI.
Summary of Aug 6's posts. Generated by AI.
Summary of Sep 30's posts. Generated by AI.
Investors talking about TENX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.